Skip to main content

BME

BlackRock Health Sciences Trust

Company with tickers: BME

CIK
1314966
CUSIP
09250W107
Shares Outstanding
12,924,103
13F Activity (30d)
33 filings 31 filers

Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.

BlackRock Health Sciences Trust

Reported 2026-03-31
Net Assets
$532,558,903
Total Assets
$536,656,640
Holdings
159
Filed
2026-05-28
Holding Balance Value % Net Assets
GOLDFINCH EQUITY WARRANTS 21,784 $0 0.00%
CONTRA FREQUENCY THERA 28,060 $0 0.00%
SWIFT HEALTH SYSTEMS INC 93 $206 0.00%
EXO IMAGING INC 1,017 $376 0.00%
Gossamer Bio Inc 31,955 $10,497 0.00%
CONTRA MIRATI THERAPEU 15,747 $12,440 0.00%
CONTRA BLUEPRINT MEDIC 15,552 $15,552 0.00%
AFFINIVAX INC 6,331 $23,235 0.00%
Autolus Therapeutics PLC 23,620 $32,596 0.01%
CONTRA ABIOMED INC 14,359 $33,313 0.01%
KARTOS THERAPEUTICS INC 34,186 $34,343 0.01%
EXO IMAGING INC 47,496 $35,147 0.01%
TScan Therapeutics Inc 48,273 $48,756 0.01%
GOLDFINCH BIO INC 168,216 $50,465 0.01%
Orchestra BioMed Holdings Inc 17,635 $74,949 0.01%
Nyxoah SA 29,659 $86,604 0.02%
4D Molecular Therapeutics Inc 11,491 $106,981 0.02%
CELLARITY INC 44,167 $107,767 0.02%
MoonLake Immunotherapeutics 5,908 $110,125 0.02%
Syndax Pharmaceuticals Inc 5,165 $120,654 0.02%
Voyager Therapeutics Inc 31,420 $121,281 0.02%
KARTOS THERAPEUTICS INC 23,610 $134,105 0.03%
BRIDGEBIO ONCOLOGY THERAPEUTICS INC 15,582 $139,459 0.03%
Corvus Pharmaceuticals Inc 9,689 $141,750 0.03%
REGENXBIO Inc 18,415 $154,318 0.03%
NUCLEIX LTD 200 $158,504 0.03%
Vor BioPharma Inc 10,020 $178,757 0.03%
Ocular Therapeutix Inc 22,645 $191,803 0.04%
Quanta Dialysis Technologies Ltd 4,243,029 $202,179 0.04%
EyePoint Inc 16,320 $210,365 0.04%
WaVe Life Sciences Ltd 30,090 $218,153 0.04%
NUCLEIX LTD 367,395 $242,481 0.05%
INSITRO INC 30,616 $255,950 0.05%
Allogene Therapeutics Inc 105,465 $257,335 0.05%
Biohaven Ltd 30,469 $257,768 0.05%
Upstream Bio Inc 30,052 $270,468 0.05%
Bicara Therapeutics Inc 14,144 $281,324 0.05%
PTC Therapeutics Inc 4,329 $294,935 0.06%
GENESIS THERAPEUTICS INC 57,170 $312,720 0.06%
BioNTech SE 3,695 $328,412 0.06%
Zealand Pharma A/S 7,187 $334,699 0.06%
CG oncology Inc 5,095 $344,830 0.06%
Beam Therapeutics Inc 14,611 $348,180 0.07%
KalVista Pharmaceuticals Inc 18,705 $376,532 0.07%
Kymera Therapeutics Inc 4,712 $392,462 0.07%
LARONDE INC 21,100 $407,652 0.08%
Aktis Oncology Inc 23,229 $415,567 0.08%
Denali Therapeutics Inc 22,218 $426,586 0.08%
Alcon AG 5,751 $433,338 0.08%
Dyne Therapeutics Inc 23,908 $433,452 0.08%
Showing 1–50 of 159 holdings